1310012-16-8
1310012-16-8
Chemical Structure
Bisoprolol-d7
- CAS No.: 1310012-16-8
- Formula:C18H24D7NO4
- Molecular Weight:332.49
InChIKey: VHYCDWMUTMEGQY-HSNISVEUSA-N
SMILES: CC(OCCOCC1=CC=C(C=C1)OCC(CNC(C([2H])([2H])[2H])(C([2H])([2H])[2H])[2H])O)C
Biological Activity: Bisoprolol-d7 is deuterium labeled Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bisoprolol-d7 | Bisoprolol-d7 is deuterium labeled Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisoprolol (Standard) | ≥98% | Bisoprolol (Standard) is the analytical standard of Bisoprolol. This product is intended for research and analytical applications. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisoprolol-d5 fumarate (2:1) | Bisoprolol-d5 fumarate (2:1) is the deuterium labeled Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisoprolol | 99.78% | Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Jillian G Baker, et al. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol. 2005 Feb;144(3):317-22. [Content Brief]
